Company Overview
GAP is a Greek pharmaceutical manufacturer with over 70 years of experience and now excels as a leading Contract Development Manufacturer in Europe and beyond.
Today, GAP is the market leader in the production of soft gelatin capsules in Greece, a regional and European leader in the manufacturing of soft gelatin capsules and a national and international driving force in the development of the nutraceutical market.
GAP is a domestic and international leader in two key areas:
- Contract development and manufacturing of soft gelatin capsules (CDMO) with a diverse portfolio of pharmaceutical and nutraceutical private label products as well
- Nutraceutical development, production, and marketing under the EVIOL brand
History
GAP’s history is one of accomplishments and continuous growth.
GAP was founded in 1949 and throughout its history it has been one of the powerhouses of the Greek pharmaceutical sector.
Its uninterrupted operation for more than 70 years, demonstrates its successful adaptation to evolving global challenges and its constant commitment to the principles of innovation and quality.
GAP has been one of the largest Greek generics companies and is now the largest softgels manufacturer in South Eastern Europe, an extroverted pharmaceutical company, exporting its products to more than 30 countries across the world.
Our Vision
Our Mission
Our Values
Responsibility:
Quality:
Flexibility:
Wellbeing:
Our Achievements
- GAP is one of Europe’s largest contract manufacturers of Isotretinoin
- GAP is the regional market leader in the production of softgel capsules
- GAP is acknowledged by clients with the highest rank in customer service among all their suppliers
- GAP has by far the largest market share in Greece for Vitamin E soft gelatin capsules
- Eviol Food Supplements are the preferred choice of Greek physicians
- Eviol Multivitamin, Eviol Multivitamin Energy Plus, Eviol Brain Function and Eviol B Complex are the best-selling products in each category